US Bancorp’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-757
| Closed | -$8.5K | – | 4299 |
|
|
2025
Q2 | $8.5K | Sell |
757
-7,756
| -91% | -$44.2K | ﹤0.01% | 3482 |
|
|
2025
Q1 | $38.9K | Sell |
8,513
-22,103
| -72% | -$148K | ﹤0.01% | 2866 |
|
|
2024
Q4 | $173K | Buy |
30,616
+11,810
| +63% | +$66.6K | ﹤0.01% | 2099 |
|
|
2024
Q3 | $91K | Buy |
18,806
+17,720
| +1,632% | +$103K | ﹤0.01% | 2442 |
|
|
2024
Q2 | $5.3K | Buy |
1,086
+760
| +233% | +$4.78K | ﹤0.01% | 3493 |
|
|
2024
Q1 | $4.33K | Hold |
326
| – | – | ﹤0.01% | 3567 |
|
|
2023
Q4 | $4.54K | Sell |
326
-130
| -29% | -$1.61K | ﹤0.01% | 3557 |
|
|
2023
Q3 | $6.05K | Hold |
456
| – | – | ﹤0.01% | 3361 |
|
|
2023
Q2 | $8.55K | Buy |
456
+286
| +168% | +$4.76K | ﹤0.01% | 3320 |
|
|
2023
Q1 | $2.45K | Sell |
170
-27
| -14% | -$529 | ﹤0.01% | 3704 |
|
|
2022
Q4 | $3.81K | Sell |
197
-6,615
| -97% | -$175K | ﹤0.01% | 3606 |
|
|
2022
Q3 | $235K | Buy |
6,812
+6,318
| +1,279% | +$202K | ﹤0.01% | 1768 |
|
|
2022
Q2 | $8K | Buy |
+494
| New | +$7.65K | ﹤0.01% | 3448 |
|
Other funds holding VERV
GCM
BIG
IA
